Molecular structure of 13-Amino-4,7,10-trioxatridecanyl-2,2′,3,3′,11,11′,12,12′-d8)-N-methyl-N-biotinylglycinamide
13-Amino-4,7,10-trioxatridecanyl-2,2′,3,3′,11,11′,12,12′-d8)-N-methyl-N-biotinylglycinamide
Molecular Weight:
525.73
Molecular Formula:
C23H35D8N5O6S
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
Streptavidin in antibody pretargeting: evaluation of methods for decreasing localization of Streptavidin to kidney while retaining its tumor binding capacity.
13-Amino-4,7,10-trioxatridecanyl-2,2′,3,3′,11,11′,12,12′-d8)-N-methyl-N-biotinylglycinamide References
Hnatowich, D., et al.: J. Nucl. Med., 1987, 28, 1294, Sung, C., et al.: Cancer Res., 54, 2166 (1994), Hashmi, M., et al.: Drug Metab. Dispos., 23, 1362 (1995), Pimm, M., et al.: Nucl. Med. Commun., 9, 931 (1988), Alvarez-Diez, T., et al.: Nucl. Med. Biol., 23, 459 (1996)Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
13-Amino-4,7,10-trioxatridecanyl-2,2',3,3',11,11',12,12'-d8)-N-methyl-N-biotinylglycinamide, 2.5 mg | sc-223164 | 2.5 mg | $7000.00 |